We support doctors with medical care for patients at home, especially those with rare metabolic diseases such as Fabry disease, Pompe disease, MPS I, MPS II, MPS IVa, MPS VI and Gaucher disease.
We are convinced that care in the familiar home environment helps improving the quality of life of every patient and their family members. By adhering to the prescribed therapy intervals, we achieve the best possible therapy success.
In addition, MHS Medical Home Service GmbH takes on tasks in the context of clinical research (blood sampling, sample processing, subcutaneous injections, intravenous therapies and their monitoring, etc.).
We systematically collect safety data (pharmacovigilance) for approved and non-approved preparations (medicines) to improve the monitoring of possible side effects and interactions.
We would be happy to advise you personally!
Sandra and Boris Delgado Sanchez
There are no models in the photos, but patients, employees and their family members. We would like to thank everyone for their support!
MHS has been working for contract research institutes, the so-called CROs, which have been involved in scientific drug research for many years. We have experience in the various specialist areas (e.g. rare diseases, dermatology, neurology, pneumology etc.).
How do I get home therapy?
If I tolerate the therapy well, the doctor will decide with me whether home therapy is an alternative for me.
If this is the case, he / she delegates this task in writing to the MHS nursing staff, including an individual emergency plan. As a patient, I consent in writing.
The documents were developed in compliance with the applicable data protection regulation.
MHS organizes the procurement of necessary medical material (e.g. infusion pump) at the patient’s request; MHS may arrange for the sterile manufacture of the individually assembled, ready-to-use and all-in-one infusion bags.
The nurse arranges the appointments with the patient. Every visit is documented and available to the doctor.
The preparation of the infusion bags takes place in clean rooms which are structured according to the scheme “A in B in C in D” and follow the guidelines of Good Manufacturing Practice (GMP), which are the international quality standard for pharmaceutical production in the pharmaceutical industry.